Literature DB >> 26379968

The correlation between HLA-DRB1 and HLA-DQB1 gene polymorphisms and cytokines in HPV16 infected women with advanced cervical cancer.

Yan Liu1, Jian Zhang2, Zhong-Ming Jia3, Ji-Chang Li1, Chun-Hua Dong1, Yong-Mei Li1.   

Abstract

OBJECTIVE: To analyze the distribution of HLA-DRB1 and HLA-DQB1 alleles and its correlation with IFN-γ, IL-2, IL-6, IL-10 in HPV16 infected women with advanced cervical carcinoma.
METHODS: We collected 137 blood samples of cervical carcinoma patients diagnosed by pathology as cervical cancer in stage IIb-IVb before the treatment, and we gathered 175 blood samples of healthy women living in the local. We determined the genetic subtypes of HLA-DRB1 and HLA-DQB1, and we measured the concentration of IFN-γ, IL-2, IL-6 and IL-10. We compared the difference of cytokines in patients with different clinical stages and the healthy in the control group. According to genetic subtypes of HLA-DRB1 and HLA-DQB1, we also compared the concentration of cytokine (CK) in different genetic subtypes.
RESULTS: Eight HLA-DRB1 alleles and four HLA-DQB1 alleles were found. There were not significant differences between each allele in the concentration of IFN-γ, IL-2, IL-6, and IL-10.
CONCLUSION: HLA-DRB1*07, HLA-DQB1*02 and HLA-DQB1*03 were the differentially expressed gene in HPV16 infected patients with advanced cervical cancer. There may be correlations between the occurrence, development of cervical cancer and IFN-γ, IL-2, IL-6, IL-10.

Entities:  

Keywords:  HLA-DQB1; HLA-DRB1; cervical cancer; cytokines; genetic polymorphism; hpv16

Year:  2015        PMID: 26379968      PMCID: PMC4565351     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

1.  Integration of the full-length HPV16 genome in cervical cancer and Caski and Siha cell lines and the possible ways of HPV integration.

Authors:  Feng Xu; Meng Cao; Qinfeng Shi; Hongwei Chen; Yili Wang; Xu Li
Journal:  Virus Genes       Date:  2015-02-10       Impact factor: 2.332

Review 2.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

3.  Annual report on status of cancer in China, 2011.

Authors:  Wanqing Chen; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Jie He
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

Review 4.  Interleukin-6 signaling pathway in targeted therapy for cancer.

Authors:  Yuqi Guo; Feng Xu; TianJian Lu; Zhenfeng Duan; Zhan Zhang
Journal:  Cancer Treat Rev       Date:  2012-05-29       Impact factor: 12.111

5.  Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Authors:  Margaret M Madeleine; Lisa G Johnson; Anajane G Smith; John A Hansen; Brenda B Nisperos; Sue Li; Lue-Ping Zhao; Janet R Daling; Stephen M Schwartz; Denise A Galloway
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

7.  Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Authors:  Ruey-Shyang Soong; Liwen Song; Janson Trieu; Jayne Knoff; Liangmei He; Ya-Chea Tsai; Warner Huh; Yung-Nien Chang; Wen-Fang Cheng; Richard B S Roden; T-C Wu; Cornelia L Trimble; Chien-Fu Hung
Journal:  Clin Cancer Res       Date:  2014-06-03       Impact factor: 12.531

8.  [Association between HPV infection and HLA-DQB1 alleles polymorphism in the cervical carcinogenesis in Uyghur women in southern Xinjiang].

Authors:  Abliz Guzalinuer; Abudu Mihrinsa; Su-qin Zhang; Hua Li; Nayimu Gulishare; Guo-qing Zhang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2010-07

9.  HLA class II susceptibility to cervical cancer among Tunisian women.

Authors:  Yosra Ben Othmane; Ezzeddine Ghazouani; Amel Mezlini; Awatef Lagha; Mejda Raïs; Radhia Kochkar; Sabrina Zidi; Mehdi Afrit; Luisa Mota-Vieira; Besma Yacoubi Loueslati
Journal:  Bull Cancer       Date:  2012-09       Impact factor: 1.276

10.  Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women.

Authors:  J Cuzick; G Terry; L Ho; J Monaghan; A Lopes; P Clarkson; I Duncan
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  1 in total

1.  HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.

Authors:  María García-Álvarez; Miguel Alcoceba; Miriam López-Parra; Noemí Puig; Alicia Antón; Ana Balanzategui; Isabel Prieto-Conde; Cristina Jiménez; María E Sarasquete; M Carmen Chillón; María Laura Gutiérrez; Rocío Corral; José María Alonso; José Antonio Queizán; Julia Vidán; Emilia Pardal; María Jesús Peñarrubia; José M Bastida; Ramón García-Sanz; Luis Marín; Marcos González
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.